Table 4.

Blood Biomarkers of Cardiovascular and Metabolic Health at Baseline and 6 and 12 Weeks After Daily Tart Cherry Juice and Control Drink Consumption

	Tart cherry (n = 9)	Control (n = 10)	Time-by-treatment, P-value
TG (mg/dL)
Baseline	173 ± 29	129 ± 27	.29
6 Weeks	148 ± 29	137 ± 27	.80
12 Weeks	162 ± 29	128 ± 27	.40
HDL-C (mg/dL)
Baseline	44 ± 2	47 ± 2	.45
6 Weeks	41 ± 2	45 ± 2	.21
12 Weeks	41 ± 2	44 ± 2	.31
LDL-C (mg/dL)
Baseline	104 ± 9	121 ± 8	.16
6 Weeks	97 ± 9	116 ± 8	.12
12 Weeks	88 ± 9	106 ± 8	.14
TAS (mg/dL)
Baseline	1.44 ± 0.06	1.49 ± 0.06	.59
6 Weeks	1.43 ± 0.06	1.54 ± 0.06	.25
12 Weeks	1.52 ± 0.06	1.51 ± 0.06	.94
Leptin (ng/mL)
Baseline	41.2 ± 7.7	44.3 ± 6.9	.76
6 Weeks	44.0 ± 7.7	44.7 ± 6.9	.95
12 Weeks	42.4 ± 7.7	44.5 ± 6.9	.84
Adiponectin (μg/mL)
Baseline	5.2 ± 0.8	5.9 ± 0.7	.52
6 Weeks	5.8 ± 0.8	5.5 ± 0.7	.79
12 Weeks	5.9 ± 0.8	6.0 ± 0.7	.87
Glucose (mg/dL)
Baseline	93 ± 15	117 ± 15	.27
6 Weeks	91 ± 15	120 ± 15	.18
12 Weeks	91 ± 15	121 ± 15	.17
Insulin (pmol/L)
Baseline	74.8 ± 14.8	70.1 ± 14.0	.82
6 Weeks	114.2 ± 14.8	84.0 ± 14.0	.15
12 Weeks	84.9 ± 14.8	72.2 ± 14.0	.54
HOMA-%B
Baseline	100.4 ± 8.9	87.8 ± 11.2	.48
6 Weeks	149.8 ± 15.5*	92.1 ± 13.4	.002
12 Weeks	126.6 ± 11.9*	88.4 ± 13.1	.035
HOMA-%S
Baseline	102.2 ± 16.0	96.6 ± 15.2	.80
6 Weeks	67.1 ± 16.0	88.0 ± 15.2	.35
12 Weeks	72.2 ± 16.0	94.5 ± 15.2	.32
HOMA-IR
Baseline	1.2 ± 0.3	1.4 ± 0.3	.72
6 Weeks	2.1 ± 0.3	1.6 ± 0.3	.21
12 Weeks	1.6 ± 0.3	1.4 ± 0.3	.65

Data are mean ± SEM.

^*Statistical significance compared to baseline.

HOMA-%B, homeostatic model assessment of beta cell function; HOMA-%S, homeostatic model assessment of insulin sensitivity; HOMA-IR, homeostatic model assessment of insulin resistance; LDL-C, low-density lipoprotein-cholesterol; TAS, total antioxidant status.